Stay updated on ASCT With Nivolumab in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the ASCT With Nivolumab in Multiple Myeloma Clinical Trial page.

Latest updates to the ASCT With Nivolumab in Multiple Myeloma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe study page now includes related-topic navigation links for Multiple Myeloma and MedlinePlus Genetics, providing quick access to background information and genetics resources.SummaryDifference0.2%

- Check16 days agoChange DetectedThe page shows a new revision tag (Revision: v3.5.4), and certain related topics/keywords (including 'Multiple Myeloma' and 'MedlinePlus Genetics') were removed from the metadata.SummaryDifference0.2%

- Check23 days agoChange DetectedRemoved references to the condition Multiple Myeloma and related topics, including MedlinePlus Genetics, from the study page. This alters the page's disease-related keywords and related-topic associations.SummaryDifference0.2%

- Check30 days agoChange DetectedThe page now includes new related topics: 'Multiple myeloma' and a link/reference to 'MedlinePlus Genetics', expanding the disease focus context and providing an accessible genetics resource.SummaryDifference0.2%

- Check37 days agoChange DetectedThe page’s revision/version indicator has been updated from v3.5.2 to v3.5.3, reflecting a minor site update rather than a change to the clinical trial details.SummaryDifference0.1%

- Check44 days agoChange DetectedAdded Revision: v3.5.2. Removed references to Multiple Myeloma and related topics (MedlinePlus Genetics) and noted Revision: v3.5.0.SummaryDifference0.2%

Stay in the know with updates to ASCT With Nivolumab in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ASCT With Nivolumab in Multiple Myeloma Clinical Trial page.